Abstract
Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design.
| Original language | English |
|---|---|
| Pages (from-to) | 234-239 |
| Number of pages | 6 |
| Journal | Journal of New Materials for Electrochemical Systems |
| Volume | 25 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 31 Dec 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 7 Affordable and Clean Energy
Keywords
- density functional theory
- drug delivery
- gemcitabine
- graphene
Fingerprint
Dive into the research topics of 'A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver